2015年深圳地区疱疹性咽峡炎的病原学与流行病学特征分析

王玉洁; 杨洪; 姚相杰; 张海龙; 陈龙; 何雅青

doi:10.16462/j.cnki.zhjbkz.2016.08.002

2015年深圳地区疱疹性咽峡炎的病原学与流行病学特征分析

doi: 10.16462/j.cnki.zhjbkz.2016.08.002

王玉洁¹,
杨洪²,
姚相杰²,
张海龙²,
陈龙²,
何雅青^1,2, ,

1. 南方医科大学公共卫生与热带医学学院流行病学系, 广东广州 510515;
2. 深圳市疾病预防控制中心微生物检验科, 广东深圳 518055

基金项目:

国家自然科学基金（81371815）

详细信息

作者简介:
王玉洁(1989-),女,河南新乡人,在读硕士研究生。主要研究方向:肠道病毒。

中图分类号: R512.51;R512.92;R181
计量
- 文章访问数: 791
- HTML全文浏览量: 172
- PDF下载量: 67
- 被引次数: 50
出版历程
- 收稿日期: 2016-04-22
- 修回日期: 2016-06-07

The etiological and epidemiological characteristics of herpangina cases in Shenzhen City, 2015

1. Department of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou 510515, China;
2. Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China

摘要

摘要: 目的分析2015年监测的深圳地区疱疹性咽峡炎的病原学情况和流行病学特征，为疱疹性咽峡炎的预防和控制提供数据基础。方法 2015年共收集深圳地区70例疱疹性咽峡炎病例粪标本,采用荧光定量RT-PCR（real time PCR，RT-PCR）和RT-snPCR（real time transcription-seminested PCR，RT-snPCR）法对样本进行肠道病毒（enterovirus，EV）检测，并对主要的流行株进行基因亚型的鉴别和系统进化分析。结果在70例疱疹性咽峡炎患者中，EV阳性率为88.57%；阳性结果中共检测出6种病毒，其中，柯萨奇病毒A6（coxsackie virus A6，CA6）和柯萨奇病毒A2（coxsackie virus A2，CA2）的阳性标本最多，分别为22例和16例，且分别占总发病病例数的31.43%和22.86%；基于核酸序列的VP1区构建的系统进化树显示，CA6毒株的基因亚型均为B型，核苷酸和氨基酸同源性分别为96.2%～100%和97.3%～100%。CA2与香港地区CA2流行株的序列高度同源，其核苷酸同源性为91.1%～99.6%，氨基酸同源性为92.4%～100%。结论 2015年深圳地区流行的病原均属于A组肠道病毒，其中B型CA6 是引起疱疹性咽峡炎的主要流行病毒株。
- 疱疹性咽峡炎 /
- 肠道病毒A型,人 /
- 柯萨奇病毒感染
Abstract: Objective To analyze the etiological and epidemic characteristics of herpangina (HA) monitored in Shenzhen City in 2015, and to provide laboratory data for the epidemic control. Methods Seventy herpangina samples were collected in Shenzhen city in 2015. RT-PCR and RT-snPCR assays were performed to detect HEVs-postive specimens. Phylogenetic tree was contructed to identify the genotype of the predominant epidemic isolates. And the nucleotide sequence homology was analyzed among Shenzhen viral sequences and others viral sequences published in GenBank. Results According to the laboratory test results, 62 cases were enterovirus positive and the positive rate was 88.57%. Among these positive cases, six serotypes of EV including CA6, CA2, CA10, EV71, CA16 and CA5 were detected. CA6 and CA2 were the predominant serotype. A total of 22 and 16 cases of herpangina were infected by CA6 and CA2 which accouted for 31.43% and 22.86% of the totcucases respectively. Phylogenetic analysis showed that all CA6 strains determined in this study were belonged to B subgenotype. The nucleotide sequences identities of the VP1 gene among CA6 strains were 96.2%-100%. The homology of amino acid of the VP1 gene among CA6 strains was 97.3%-100%. The VP1 sequences of Shenzhen CA2 isolates shared high similarity with those of Hong Kong isolates. And their homologies of nucleotide and amino acid sequences were 91.1%-99.6% and 92.4%-100%, respectively. Conclusions A total of six different serotypes were detected in this study in which all six serotypes belonged to HEV-A species. And subgenotype B virus of CA6 may play an important role in the development of herpangina and it was the predominant etiologic agent of herpangina cases in this study.
- Herpangina /
- Enterovirus A, human /
- Coxsackievirus infections

HTML全文

参考文献(21)

Sano T, Saito T, Kondo M, et al. Enterovirus detection status of patients with herpangina and hand, foot and mouth disease in epidemic season 2007, Kanagawa Prefecture, Japan [J]. Jpn J Infect Dis, 2008,61(2):162-163.

Chen KT, Chang HL, Wang ST, et al. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005 [J]. Pediatrics, 2007,120(2):e244-252.

Puenpa J, Mauleekoonphairoj J, Linsuwanon P, et al. Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012 [J]. PLoS One, 2014,9(6):e98888.

Chen YH, Lin HC, Lin HC. Increased risk of adverse pregnancy outcomes among women affected by herpangina [J]. Am J Obstet Gynecol, 2010,203(1):49.e1-7.

Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71 [J]. Lancet Infect Dis, 2010,10(11):778-790.

Shah VA, Chong CY, Chan KP, et al. Clinical characteristics of an outbreak of hand, foot and mouth disease in Singapore [J]. Ann Acad Med Singapore, 2003, 32(3):381-387.

Chang LY, King CC, Hsu KH, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan [J]. Pediatrics, 2002,109(6):e88.

蔡春林,姚相杰,卓菲,等. 深圳地区疱疹性咽峡炎疫情的柯萨奇病毒A4型VP1区基因特征分析 [J]. 中华医学杂志, 2015,95(16):1226-1229.

Mirand A, Schuffenecker I, Henquell C, et al. Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries [J]. J Gen Virol, 2010,91(Pt 9):2263-2277.

Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens [J]. J Clin Microbiol, 2006,44(8):2698-2704.

Yip CC, Lau SK, Woo PC, et al. Recombinant coxsackievirus A2 and deaths of children, Hong Kong, 2012 [J]. Emerg Infect Dis, 2013,19(8):1285-1288.

Chen SP, Huang YC, Li WC, et al. Comparison of clinical features between coxsackievirus A2 and enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: a children's hospital experience [J]. J Microbiol Immunol Infect, 2010, 43(2):99-104.

李佳萌,李琳,吕莉琨,等. 2014年天津市肠道病毒所致疱疹性咽峡炎临床流行病学分析 [J]. 中华疾病控制杂志, 2016,20(1):26-29.

王宏宇,张小爱,许红梅,等. 手足口病患者不同标本中肠道病毒检测结果比较 [J]. 中华疾病控制杂志, 2014,18(6):501-503.

Crawford NW, Graham SM. EV71 vaccine: protection from a previously neglected disease [J]. Lancet, 2013,381(9882):1968-1970.

Miyazawa I, Azegami Y, Kasuo S, et al. Prevalence of enterovirus from patients with herpangina and hand, foot and mouth disease in Nagano Prefecture, Japan, 2007 [J]. Jpn J Infect Dis, 2008,61(3):247-248.

Mirand A, Henquell C, Archimbaud C, et al. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study [J]. Clin Microbiol Infect, 2012,18(5):E110-E118.

El Houmami N, Minodier P, Dubourg G, et al. An outbreak of Kingella kingae infections associated with hand, foot and mouth disease/herpangina virus outbreak in Marseille, France, 2013 [J]. Pediatr Infect Dis J, 2015,34(3):246-250.

Yamashita T, Ito M, Taniguchi A, et al. Prevalence of coxsackievirus A5, A6, and A10 in patients with herpangina in Aichi Prefecture, 2005 [J]. Jpn J Infect Dis, 2005,58(6):390-391.

Bracho MA, González-Candelas F, Valero A, et al. Enterovirus co-infections and onychomadesis after hand, foot, and mouth disease, Spain, 2008 [J]. Emerg Infect Dis, 2011,17(12):2223-2231.

Huang Y, Zhou Y, Lu H, et al. Characterization of severe hand, foot, and mouth disease in Shenzhen, China, 2009-2013 [J]. J Med Virol, 2015,87(9):1471-1479.

施引文献

期刊类型引用(35)

1.	李明. 2018—2022年驻马店市731例疱疹性咽峡炎流行病学及病原学特征分析. 河南医学高等专科学校学报. 2024(02): 217-220 . 百度学术
2.	潘倩瑜，杨洪，何雅青，陈龙，张海龙，姚相杰，张仁利，孟君. 2021年深圳地区疱疹性咽峡炎流行病学与病原学特征分析. 热带医学杂志. 2023(07): 900-903+913 . 百度学术
3.	陈龙，杨洪，姚相杰，孟君，张海龙，张仁利，何雅青. 2017-2018年广东省深圳市疱疹性咽峡炎患者肠道病毒分子流行病学研究. 疾病监测. 2023(09): 1048-1053 . 百度学术
4.	孟君，杨洪，陈龙，潘倩瑜，张海龙，姚相杰，何雅青. 2019年深圳地区疱疹性咽峡炎流行病学及病原学监测研究. 国际病毒学杂志. 2023(06): 482-486 . 百度学术
5.	吴金凤. 681例疱疹性咽峡炎患儿的流行病学特征及血象特点分析. 妇儿健康导刊. 2023(22): 80-82 . 百度学术
6.	黄妙芬，王文祥，连宪强，杨粤. 深圳市大鹏新区2起儿童疱疹性咽颊炎聚集性疫情的病原鉴定与基因分型分析. 上海预防医学. 2022(07): 660-664 . 百度学术
7.	叶冰，孙文慧. 喉咽清口服液联合开喉剑喷雾剂治疗小儿疱疹性咽峡炎的临床疗效及其安全性. 临床合理用药杂志. 2021(21): 51-54 . 百度学术
8.	李梅，文洁珍. 泻黄散加减治疗心脾积热型小儿疱疹性咽峡炎临床研究. 山东中医杂志. 2020(01): 30-33 . 百度学术
9.	王业芳，钟艳. 北京朝阳区幼儿2016—2018学年度传染病患病状况. 中国学校卫生. 2020(05): 789-791 . 百度学术
10.	黎芳，唐智超. 2016-2017年北京市顺义区疱疹性咽峡炎及手足口病流行特征及病原学监测分析. 中国农村卫生. 2020(11): 44-47 . 百度学术
11.	胡新军，李剑雄. 蒲地蓝消炎口服液联合喜炎平注射液治疗疱疹性咽峡炎幼儿的临床疗效及对炎症因子的影响. 当代医学. 2020(24): 10-13 . 百度学术
12.	赵天朔，杜娟，刘翰谕，刘雅琼，崔富强，卢庆彬. 疱疹性咽峡炎流行病学及病原学研究进展. 中国病毒病杂志. 2020(05): 385-390 . 百度学术
13.	王华，沈晓凤. 浙江省嘉兴市0～6岁儿童疱疹性咽峡炎的流行病学特征及相关危险因素分析. 中国药物与临床. 2019(03): 367-369 . 百度学术
14.	许少坚，郝夏琼，任燕，姚相杰，陈龙，全德甫，赖晓玲，满云翔，刘佳娴，曹赫，林启辉. 深圳市龙华区疱疹性咽峡炎病原学特点. 中国热带医学. 2019(03): 267-270 . 百度学术
15.	周万航，李嫣斐. 疱疹性咽峡炎临床研究进展. 深圳中西医结合杂志. 2019(04): 179-182 . 百度学术
16.	贺仪松，陈佩宣. 疱疹性咽峡炎小儿心肌酶谱与超敏C–反应蛋白检测的临床意义. 深圳中西医结合杂志. 2019(05): 9-10 . 百度学术
17.	杨杨，李东野. 疏风解毒胶囊联合重组α1b干扰素治疗小儿疱疹性咽峡炎的疗效观察. 中国中医急症. 2019(05): 899-900 . 百度学术
18.	刘潇潇，李华，王永全，孔庆征，黄艳红，张军颖，崔海洋，靳博. 2017年北京儿童医院就诊北京地区疱疹性咽颊炎病例分析. 疾病监测. 2019(05): 401-405 . 百度学术
19.	贾国华，韩小伟，张进国，贾红梅，张今文. 小儿疱疹性咽峡炎中西医研究概况分析. 医学动物防制. 2019(09): 856-861 . 百度学术
20.	付毅臣，刘磊，王珊. 疱疹性咽峡炎患儿血常规和外周血细胞形态学分析. 河南医学研究. 2019(12): 2260-2261 . 百度学术
21.	麦庆锋，吴梓坤，柴慧颖，程欢，杨笑涵，刘攀. 2018年Cox-A6感染性手足口病住院患儿82例临床特征和病原学分析. 广东医学. 2019(13): 1884-1888 . 百度学术
22.	高德静，程燕，郭素香. 程燕辨治疱疹性咽峡炎经验. 上海中医药杂志. 2019(08): 38-40 . 百度学术
23.	李俊华，张平中. 牛蒡翘荷汤配合耳穴压豆治疗儿童疱疹性咽峡炎临床研究. 新中医. 2019(09): 184-186 . 百度学术
24.	方玉红，崔晓明，周琳. 婴幼儿疱疹性咽峡炎外周血白细胞、C-反应蛋白变化情况及抗生素应用效果和安全性评估. 中国妇幼保健. 2019(19): 4478-4480 . 百度学术
25.	苗新鑫. 干扰素雾化吸入联合炎琥宁治疗小儿疱疹性咽峡炎的疗效观察. 中国医药指南. 2019(29): 159-160 . 百度学术
26.	牛涛，王文瑞，田晓灵. 小儿疱疹性咽峡炎和手足口病的对比研究评价. 全科口腔医学电子杂志. 2018(20): 16-18 . 百度学术
27.	徐文志，肖忠. 鱼腥草治疗疱疹性咽峡炎的临床疗效观察. 中医临床研究. 2018(16): 64-65 . 百度学术
28.	张惠，段捷华. 抗病毒口服液联合热炎宁颗粒治疗疱疹性咽峡炎的疗效观察. 临床合理用药杂志. 2018(31): 32-33 . 百度学术
29.	李湘津，李玉梅，颜娟. 百蕊颗粒联合利巴韦林喷剂治疗小儿疱疹性咽峡炎的疗效观察. 中国医药指南. 2018(28): 25+27 . 百度学术
30.	卢亚亚. 四季抗病毒联合碘甘油治疗疱疹性咽峡炎患儿的疗效. 实用中西医结合临床. 2018(10): 40-42 . 百度学术
31.	王颖. 探讨更昔洛韦治疗疱疹性咽峡炎的临床疗效和药理作用. 中国继续医学教育. 2017(17): 174-175 . 百度学术
32.	张苏棉，王利利，郭小丽. 干扰素雾化联合口服补液盐治疗疱疹性咽峡炎的疗效研究. 检验医学与临床. 2017(10): 1407-1409 . 百度学术
33.	董丹. 喜炎平注射液雾化吸入治疗儿童疱疹性咽峡炎临床分析. 辽宁中医药大学学报. 2017(06): 184-186 . 百度学术
34.	宋自强，陈春宝，张璇. 特异性肠道病毒鸡卵黄抗体喷剂治疗疱疹性咽峡炎患儿口腔疱疹的疗效. 中国妇幼保健. 2017(19): 4716-4718 . 百度学术
35.	蒋霞. 炎琥宁联合干扰素雾化吸入治疗小儿疱疹性咽峡炎的临床效果. 中国当代医药. 2017(09): 68-70 . 百度学术